Kolon TissueGene, Inc.

Kolon TissueGene, Inc. Share · KR8840120008 (XKOS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kolon TissueGene, Inc.
No Price
Closing Price XKOS 30.04.2026: 102.000,00 KRW
30.04.2026 06:30
Current Prices from Kolon TissueGene, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
950160.KQ
KRW
30.04.2026 06:30
102.000,00 KRW
-
Company Profile for Kolon TissueGene, Inc. Share
Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.

Company Data

Name Kolon TissueGene, Inc.
Company Kolon TissueGene, Inc.
Website https://www.kolontissuegene.com
Primary Exchange XKOS KOSDAQ
ISIN KR8840120008
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 8.489 Mrd.
Country United States of America
Currency KRW
Employees -
IPO Date 2017-11-06

Ticker Symbols

Name Symbol
KOSDAQ 950160.KQ
More Shares
Investors who hold Kolon TissueGene, Inc. also have the following shares in their portfolio:
D.TRUCKS NA 23/28 REGS
D.TRUCKS NA 23/28 REGS Bond
DT.TELEK.INTL F.08/23 MTN
DT.TELEK.INTL F.08/23 MTN Bond